Creso Pharma Ltd
ASX:CPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Meridianlink Inc
NYSE:MLNK
|
US |
|
Spectris PLC
LSE:SXS
|
UK |
|
B
|
Big Yellow Group PLC
OTC:BYLOF
|
UK |
Creso Pharma Ltd
Total Receivables
Creso Pharma Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Creso Pharma Ltd
ASX:CPH
|
Total Receivables
AU$4.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Total Receivables
AU$52.1k
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Total Receivables
AU$181.9m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Total Receivables
AU$26.5m
|
CAGR 3-Years
105%
|
CAGR 5-Years
104%
|
CAGR 10-Years
97%
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Total Receivables
AU$10.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Nyrada Inc
ASX:NYR
|
Total Receivables
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Creso Pharma Ltd
Glance View
Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. The firm is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. The Company, through its subsidiary is also engaged in cultivates and harvests cannabis plants and supplies dried cannabis plant retail products. The firm is operating medical facility in Windsor, Nova Scotia with 6 treatment rooms and a laboratory dedicated to performing psychedelic-assisted psychotherapy and clinical research.
See Also
What is Creso Pharma Ltd's Total Receivables?
Total Receivables
4.7m
AUD
Based on the financial report for Dec 31, 2022, Creso Pharma Ltd's Total Receivables amounts to 4.7m AUD.
What is Creso Pharma Ltd's Total Receivables growth rate?
Total Receivables CAGR 1Y
327%
Over the last year, the Total Receivables growth was 327%.
